Sector revisions Northwest Biotherapeutics, Inc. Börse Stuttgart

Stocks

Market Closed - Börse Stuttgart 05:56:48 02/10/26 am AEST			5-day change	1st Jan Change
0.1220 ^EUR	-6.87%		-14.08%	-40.78%

15/08	Northwest Biotherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07/08	Northwest Biotherapeutics and Saudi Pharmaceutical Industries and Medical Appliance Company Enter Memorandum of Understanding for Collaboration	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. EPS revision	Nbr of analysts
WUXI APPTEC CO., LTD.		18
ARGENX SE		15
LONZA GROUP AG		23
IQVIA HOLDINGS INC.		19
REVOLUTION MEDICINES, INC.		22
BEONE MEDICINES AG		28
CELLTRION, INC.		22
WUXI BIOLOGICS (CAYMAN) INC.		24
INSMED INCORPORATED		23
BIONTECH SE		20
GENMAB A/S		15
MEDPACE HOLDINGS, INC.		13
PHARMAESSENTIA CORPORATION		8
EUROFINS SCIENTIFIC SE		14
ASCENDIS PHARMA A/S	-	20
TEMPUS AI, INC.		18
EXELIXIS, INC.		15
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.		19
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.		15
Average		18
Weighted average by Cap.		19